About Baronio Fund Opportunities Board Lab Directory Industry Partners Join PSRC Members Only
PSRC on Facebook PSRC on Instagram PSRC on Twitter PSRC on Youtube

Back to 2021 Virtual Presentations




Multidisciplinary care and adjuvant radiation therapy have both been shown to improve outcomes in breast cancer, however radiation can have devastating effects on breast skin and soft tissues, ultimately resulting in delayed surgical wound healing and possibly reconstructive failure. In this study, Jared Liston, MD @listonj1 @dr.jaredliston and his coauthors in the University of Virginia Departments of Plastic Surgery @uvaplasticsurgeryresidency and Radiation Oncology @uvaradonc @uvahealth @uvaschoolofmedicine @uva describe a possible relationship between treatment with adjuvant capecitabine (Xeloda #xeloda) and decreased radiation skin toxicity in implant-based breast reconstruction patients who also received adjuvant radiation therapy. In this retrospective review, patients who received adjuvant Xeloda had significantly decreased chronic radiation toxicity at 12 months post-radiation. Future research into the relationship between chemotherapy and radiation and their effects on healthy tissues will continue to increase the quality of oncologic and reconstructive care that our patients receive. @americancancersociety @thinkpink_breastcancer @susangkomen @breastrecon_usa

Back to 2021 Virtual Presentations